- Halozyme Therapeutics (NASDAQ:HALO): Q3 EPS of -$0.23 beats by $0.04.
- Revenue of $31.9M (+53.5% Y/Y) misses by $1.96M.
- Press Release
Halozyme Therapeutics beats by $0.04, misses on revenue
Recommended For You
More Trending News
About HALO Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| HALO | - | - |
| Halozyme Therapeutics, Inc. | ||